Dermatology Biotech Bambusa Slides 7% After $168.9 Million IPO

How 1 sources are covering this

• BloombergLean L·3h ago

  Dermatology Biotech Bambusa Slides 7% After $168.9 Million IPO

  Bambusa Therapeutics Inc. shares slipped 7% in its trading debut after the early-stage biotech focused on dermatology and autoimmune diseases raised $168.9 million in a US initial public offering.

  Read at Bloomberg →